PE20000020A1 - Composiciones para el tratamiento del sida e infeccion del vih - Google Patents

Composiciones para el tratamiento del sida e infeccion del vih

Info

Publication number
PE20000020A1
PE20000020A1 PE1998001094A PE00109498A PE20000020A1 PE 20000020 A1 PE20000020 A1 PE 20000020A1 PE 1998001094 A PE1998001094 A PE 1998001094A PE 00109498 A PE00109498 A PE 00109498A PE 20000020 A1 PE20000020 A1 PE 20000020A1
Authority
PE
Peru
Prior art keywords
hydroxy
hiv infection
aids
nucleosid
refers
Prior art date
Application number
PE1998001094A
Other languages
English (en)
Inventor
Jeffrey A Chodakewitz
Joseph P Vacca
William D Ju
Jiunn H Lin
Kuang C Yeh
Paul J Deutsch
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9807938.7A external-priority patent/GB9807938D0/en
Priority claimed from GBGB9819590.2A external-priority patent/GB9819590D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PE20000020A1 publication Critical patent/PE20000020A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE a)UN INHIBIDOR DE PROTEASA DE VIH DE FORMULA A, N-(2(R)-HIDROXI-1(S)-INDALIL)-2(R)-FENILMETIL-4-(S)-HIDROXI-5-(1-(4-(2-BENZO(b)FURANILMETIL)-2(S)-N`-(t-BUTILCARBOXAMIDO)-PIPERAZINIL))-PENTANOAMIDA; b)UNO O MAS AGENTES ANTIRETROVIRALES INHIBIDORES DE TRANSCRIPTASA INVERSA NUCLEOSIDOS O NO NUCLEOSIDOS COMO ZIDOVUDINA, LAMIVUDINA, STAVUDINA, RITONAVIR, NELFINAVIR, ABACAVIR, INDINAVIR, DELAVIRDINA, (-)-6-CLORO-4-CICLOPROPILETINIL-4-TRIFLUOROMETIL-1,4-DIHIDRO-2H-3,1-BENZOXACIN-2-ONA, 4-AMINO-N-((2,3S)-2-HIDROXI-4-FENIL-3-((S)-TETRAHIDROFURANO-3-ILOXICARBONILAMINO)-BUTIL)-N-ISOBUTIL-BENCENOSULFONAMIDA; ESTAN PRESENTES EN UNA PROPORCION DE 2:1 A 1:2. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. LA COMPOSICION PUEDE SER UTIL PARA TRATAR O PREVENIR LA INFECCION POR VIH, TRATAR EL SIDA
PE1998001094A 1997-11-13 1998-11-12 Composiciones para el tratamiento del sida e infeccion del vih PE20000020A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6542197P 1997-11-13 1997-11-13
GBGB9807938.7A GB9807938D0 (en) 1998-04-15 1998-04-15 Combination therapy for the treatment of AIDS
US9094098P 1998-06-26 1998-06-26
GBGB9819590.2A GB9819590D0 (en) 1998-09-08 1998-09-08 Combination therapy for the treatment of aids

Publications (1)

Publication Number Publication Date
PE20000020A1 true PE20000020A1 (es) 2000-01-27

Family

ID=27451773

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998001094A PE20000020A1 (es) 1997-11-13 1998-11-12 Composiciones para el tratamiento del sida e infeccion del vih

Country Status (24)

Country Link
EP (1) EP1044000B1 (es)
JP (1) JP2001522889A (es)
KR (1) KR20010032055A (es)
CN (1) CN1285747A (es)
AR (1) AR013758A1 (es)
AT (1) ATE218866T1 (es)
AU (1) AU749795B2 (es)
BG (1) BG104507A (es)
BR (1) BR9814146A (es)
CA (1) CA2309164A1 (es)
CO (1) CO4970782A1 (es)
DE (1) DE69806062T2 (es)
EA (1) EA200000513A1 (es)
ES (1) ES2177103T3 (es)
HU (1) HUP0100365A3 (es)
ID (1) ID24922A (es)
IL (1) IL135994A0 (es)
IS (1) IS5481A (es)
NO (1) NO20002481L (es)
PE (1) PE20000020A1 (es)
PL (1) PL340430A1 (es)
SK (1) SK6842000A3 (es)
TR (1) TR200001938T2 (es)
WO (1) WO1999025352A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
WO2003011221A2 (en) 2001-07-30 2003-02-13 University Of Southern California PREPARATION AND USE OF α-KETO PHOSPHONATES
KR20080032014A (ko) 2003-01-14 2008-04-11 길리애드 사이언시즈, 인코포레이티드 복합 항바이러스 치료를 위한 조성물 및 방법
GB2400553A (en) * 2003-04-14 2004-10-20 Cipla Ltd Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174921T3 (es) * 1993-12-15 2002-11-16 Merck & Co Inc Inhibidores de la proteasa del vih.

Also Published As

Publication number Publication date
ID24922A (id) 2000-08-31
IS5481A (is) 2000-05-09
EA200000513A1 (ru) 2000-10-30
BR9814146A (pt) 2000-10-03
NO20002481D0 (no) 2000-05-12
DE69806062T2 (de) 2003-03-20
AU749795B2 (en) 2002-07-04
AU1522599A (en) 1999-06-07
CO4970782A1 (es) 2000-11-07
SK6842000A3 (en) 2000-12-11
JP2001522889A (ja) 2001-11-20
IL135994A0 (en) 2001-05-20
EP1044000A1 (en) 2000-10-18
HUP0100365A3 (en) 2002-06-28
ATE218866T1 (de) 2002-06-15
WO1999025352A1 (en) 1999-05-27
PL340430A1 (en) 2001-02-12
DE69806062D1 (de) 2002-07-18
BG104507A (bg) 2001-03-30
TR200001938T2 (tr) 2001-07-23
AR013758A1 (es) 2001-01-10
CA2309164A1 (en) 1999-05-27
HUP0100365A2 (hu) 2002-05-29
NO20002481L (no) 2000-07-12
KR20010032055A (ko) 2001-04-16
CN1285747A (zh) 2001-02-28
EP1044000B1 (en) 2002-06-12
ES2177103T3 (es) 2002-12-01

Similar Documents

Publication Publication Date Title
PE20110236A1 (es) Proteccion y mejoramiento de celulas, tejidos y organos que responden a la eritropoyetina
PT1318791E (pt) Composicao farmaceutica semi-solida de isotretinoina
BRPI0113162B8 (pt) compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos
BR0113286A (pt) Pirazóis substituìdos
BR9807098A (pt) Antagonistas de endotelina: n[[2'-[[(4,5-dimetil-3-isoxazolil)amino]sulfonil]-4-(2-oxa zolil)[1,1'-bi-fenil]-2-il]-n,3,3-trimetilbutanamida e n-(4,5-dimetil-3-isoxazolil)-2'-[(3,3-dimetil-2-oxo-1-pirro lidinil) metil]-4'-2-oxazolil)[1,1' -bifenil]-2-sulfonamida e sais dos mesmos
BR0213207A (pt) remodelagem e glicoconjugação de peptìdeos
MX9403380A (es) Inhibidores de proteasa de vih utiles para el tratamiento de sida.
PA8513601A1 (es) Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa
BR0015056A (pt) Composto, uso de um composto, composição farmacêutica, método de tratamento de infecções por hiv e kit farmacêutico
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
BRPI0510870A (pt) composição resistente ao impacto
BR0000654A (pt) Preparação de composição de borracha vulcanizada com peróxido e artigos tendo ela pelo menos como um dos seus componentes
CO5440227A1 (es) Composicion antihelmitica e inyectable mejorada de crecimiento
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
PE20000020A1 (es) Composiciones para el tratamiento del sida e infeccion del vih
ES2174921T3 (es) Inhibidores de la proteasa del vih.
DE69732709D1 (de) Expressionsblockierung von virulenten faktoren in s. aureus
CO5280222A1 (es) Composicion farmaceutica que comprende pemetrexed
ES2179093T3 (es) Inhibidores de la prolilendopeptidasa.
DE60139553D1 (de) Zusammensetzungen, testsätze und methoden zur identifizierung und modulation von typ i diabetes
ES2069536T3 (es) Analogos del activador del plasminogeno tisular que tienen dominios modificados del factor de crecimiento.
BR0114082A (pt) Compostos, composições farmacêuticas, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas
ES2127349T3 (es) Aditivos polimeros mejoradores del flujo.
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
DK0506769T3 (da) Farmaceutisk præparat til behandling eller forebyggelse af retrovirus-infektioner

Legal Events

Date Code Title Description
FC Refusal